Skin cancer drug nearly doubles survival in majority of patients

Thursday, February 23, 2012 - 00:00 in Health & Medicine

Vanderbilt-Ingram Cancer Center researchers helped lead trial Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new...

Read the whole article on Science Blog

More from Science Blog

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net